1. Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial. Issue 10317 (11th December 2021) Authors: Ella, Raches; Reddy, Siddarth; Blackwelder, William; Potdar, Varsha; Yadav, Pragya; Sarangi, Vamshi; Aileni, Vinay K; Kanungo, Suman; Rai, Sanjay; Reddy, Prabhakar; Verma, Savita; Singh, Chandramani; Redkar, Sagar; Mohapatra, Satyajit; Pandey, Anil; Ranganadin, Pajanivel; Gumashta, Raghavendra; M... Journal: Lancet Issue: Volume 398:Issue 10317(2021) Page Start: 2173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. IDF21-0182 Evaluating diabetes related distress in people with Type 2 DM – Insights from Diabefly Digital Therapeutics Platform. (April 2022) Authors: Verma, N.; Vasan, P.; Bafna, V.; Verma, R.; Ranadive, R.; Malde, F.; Kalra, S.; Lathia, T.; Raskar, V.; Kulkarni, S.; Joshi, S.; Singal, A. Journal: Diabetes research and clinical practice Issue: Volume 186:Supplement 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Outcome of autologous stem cell transplantation in multiple myeloma, in the era of novel agents: a single-centre experience. (October 2019) Authors: Bafna, V.; Damodar, S.; Bendi, C. Journal: Leukemia research Issue: Volume 85(2019)Supplement 1 Page Start: S41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗